Meeting report

Click on the link below to download the meeting report. This report features session highlights, video clips and selected figures from the meeting.


25th May 2018, Hotel Vier Jahreszeiten Kempinski, Munich, Germany

10:00–10:40Welcome – Prediction and prevention of type 1 diabetes in childrenReinhard Holl
10:40–11:20Acute complications: diabetic ketoacidosisKlemens Raile
11:20–11:40Coffee break 
11:40–12:20Acute complications: hypoglycaemiaReinhard Holl
12:20–13:00Chronic complicationsKlemens Raile
13:00–14:00Lunch break 
14:00–15:00Practical insulin treatmentBeate Karges
15:00–15:15Coffee break 
15:15–16:45Advances in technology for diabetes treatmentThomas Danne
16:45–17:00Summary and closing remarksReinhard Holl

Learning objectives

Following this meeting, delegates will be able to:

  • Estimate the risk of, and understand how to predict and possibly prevent, type 1 diabetes in children and adolescents
  • Assess the risks of, and effectively manage, acute and chronic complications of type 1 diabetes
  • Discuss the best treatment options, including new insulins and advanced technologies, for maintaining optimal glucose control


This activity has been approved by Bayerische Landesärztekammer for a total of 7 CME credits.


Hotel Vier Jahreszeiten Kempinski Munich, Maximilianstraße 17, 80539 München, Germany


Head of Staff Unit, Central Institute for Biomedical Technology
University of Ulm, Ulm

Reinhard Holl is a paediatric endocrinologist and diabetologist, and the clinical lead at the Institute for Epidemiology and Medical Biometry at the University of Ulm.

Professer Holl studied at the University of Ulm and Hannover Medical School before specialising in internal medicine and paediatrics. He undertook his research fellowship at the University of Virginia, USA and also completed a postdoctoral lecture qualification for paediatrics. He went on to become a senior clinical physician with a subspecialty in diabetology. In 1998, he started as clinical senior physician at the University Children’s Hospital in Giessen, to go onto become acting department head and then associate professor.

His research interests include medical quality management, hierarchical mixed modelling in observational studies, long-term treatment courses in chronic disorders (diabetes, obesity, endocrinology) and diabetes classification.

Professor Holl is on the board of the Dr Heinz Bürger-Büsing Stiftung and is on the German Diabetes Association Commission for Quality Management, Patient Education and Professional Training; Social Issues; and Diabetes Registries and Healthcare Research. He is also the chair of the Working Group on Diabetology in Baden-Württemberg for the same body.

Since 2000 he has been involved in a working group for computer-assisted quality monitoring in medicine standardized documentation for patients with diabetes (DPV), obesity (APV) congenital hypothyroidism (AQUAPE-Hypo) or congenital adrenal hyperplasia (AQUAPE-AGS) biometrical statistics, conduction and analyses, clinical research studies.

Head of the Department of Endocrinology and Diabetology, Charité
University Medicine, Berlin

Klemens Raile is head of department of paediatric endocrinology and diabetology at the Virchow Clinic in the Charité University of Medicine in Berlin.

He attended medical school at the Technical University in Munich and moved to Ludwig-Maximilians University in Munich to complete his MD qualification. After training at the Paediatric University Children’s Hospital he moved to the Children’s Hospital at the University of Leipzig, training in paediatric intensive care, paediatric endocrinology and general paediatrics.

In 2005, Professor Raile became head of the Paediatric Diabetes Center at the Charite University of Medicine in Berlin before becoming consultant paediatrician and then senior consultant, group leader and later head of department at the same institution.

His research includes following more than 500 children and adolescents with diabetes mellitus. It targets all aspects of paediatric diabetes with special focus on investigating new molecular mechanisms in patients with diabetes of unknown origin, leading to establishing a cohort of rare diabetes phenotypes including syndromal diabetes, neonatal diabetes and familial diabetes. This led to developing highly individualised treatments for more effective outcomes.

Senior Physician in Paediatric Endocrinology and Diabetes
RWTH Aachen University, Aachen

Beate Karges is a senior physician in paediatric endocrinology and diabetes at Bethlehem Hospital Stolberg and an associate professor in the Division of Endocrinology and Diabetes at RWTH Aachen University.

She graduated in 1989 and completed her doctorate in 1990 at the medical school of RWTH Aachen University. She then trained in paediatrics and paediatric endocrinology at Vestische Kinderklinik Datteln, Germany and in 1997 became a specialist in paediatrics.

Professor Karges was a postdoctoral research fellow from 1999 to 2001 of the European Society of Paediatric Endocrinology (ESPE) in the INSERM U135 Research Unit of Hormones, Genes and Reproduction at the Bicêtre Hospital in Paris, France. Following this, between 2002 and 2008, she became a research Fellow and senior physician in paediatric endocrinology and diabetes, in the department of paediatrics at Ulm University. During this time she completed a postdoctoral lecture qualification, became a specialist in paediatric endocrinology and diabetes and was made Associate Professor in 2007.

She has contributed to more than 100 published works and won several awards in the field of paediatric endocrinology and diabetes.

Professor of Paediatrics, Chief Physician, Diabetes Center for Children and Adolescents
AUF DER BULT, Hannover

Thomas Danne is director of the department of general paediatrics endocrinology, diabetology & clinical research at the Auf der Bult Hospital for Children and Adolescents in Hannover , Germany.

He is currently chairman of the SWEET-project and work-package leader of the INNODIA-project. He is also a past-president of the International Society for Paediatric and Adolescent Diabetes (ISPAD), the German Diabetes Association (DDG) and the German Diabetes Aid (diabetesDE). He is a former research Fellow of the Joslin Diabetes Center of Harvard Medical School in Boston.
His research interests include basic and clinical research in diabetology with special emphasis on type 1 diabetes treatment, new insulins, insulin pumps, glucose sensors and the artificial pancreas.

Recently he has been awarded the “lifetime achievement award” of the International Diabetes Federation (IDF). Professor Danne has published over 200 peer reviewed papers, is on the editorial board of several journals and has contributed to several books.

Educational grant

This programme is made possible thanks to an independent educational grant from Novo Nordisk A/S.


MMPAD secretariat
Telephone +44 (0) 203 192 2023
Springer Healthcare IME
4 Crinan Street
London, N1 9XW, UK